Colon Cancer Applications
-
Drug Dolution for Gastric Cancer
Gastric cancer is a disease in which cancer cells form in the lining of the stomach. Almost all gastric cancers are adenocarcinomas, a cancer that begins in glandular tissue. Gastric cancer is often in an advanced stage when it is diagnosed. At this stage, it can often be treated, but rarely ...
By Ascelia Pharma AB based in Malmö, SWEDEN.
-
Drug Dolution for Liver Metastases
One of the that cancer can be a serious disease is its ability to spread to other parts of the body beyond the location of the primary tumour. When cancer cells spread to distant lymph nodes, tissues or organs, it is called metastatic ...
By Ascelia Pharma AB based in Malmö, SWEDEN.
-
Diagnostic Solutions for Colorectal Cancer
Standard treatment for advanced colorectal cancer generally involves surgical resection and chemotherapy. However, the recent emergence of targeted therapies, particularly those that inhibit EGFR, has provided treatment options that extend survival for a subset of patients. Unfortunately, this benefit does not extend to patients whose tumors contain mutations in EGFR signaling components KRAS and BRAF, which together represent 50% of all colorectal cancers. This makes characterizing these molecular markers an ...
By Biocept based in San Diego, CALIFORNIA (USA).
-
Robotic-Assisted Bronchoscopy System for Lung Cancer Statistics
Lung cancer is the leading cause of cancer deaths worldwide. More Americans die each year from lung cancer than from prostate, breast and colon cancers ...
By Auris Health, Inc. based in Redwood City, CALIFORNIA (USA).
-
Medical diagnostics solutions for inflammatory bowel disease sector
Inflammatory bowel disease (IBD), largely comprising the two conditions, Crohn’s Disease and Ulcerative Colitis, is now emerging as a global health problem. It now affects about 6 million people in Europe and US, comprising up to 620,000 in the UK (IBD Standards UK, 2013 Update). The symptoms of diarrhoea, abdominal pain and bloody stool substantially affect the quality of life of sufferers, and complications can be life threatening. IBD is also strongly associated with colorectal cancer development risk. ...
By DiagNodus Ltd. based in Cambridge, UNITED KINGDOM.
-
Quench - Aerosol Platform Technology for Lung Cancer
Despite the use of aggressive surgery and combination chemotherapy, lung cancer remains difficult to control and is the biggest killer among cancers at 154,000 annual US deaths. Lung cancer kills more people per year than prostate, pancreas, breast, and colon cancers combined. ...
By Quench Medical Inc. based in St Paul, MINNESOTA (USA).
-
Colovac - Flexible Endoluminal Bypass Sheath for Patients
Colorectal cancer is the third most commonly occurring cancer in men and the second most commonly occurring cancer in women. There were over 1.8 million new cases worldwide in 2018. Generally colorectal cancer is being treated with surgery by cutting away the diseased part in the rectum and joining the two new ends together resulting in an anastomosis (which is the resultant ...
By SafeHeal based in Paris, FRANCE.
-
Immunoscore for Colon Cancer Patients
To date, the classification of cancers has been based solely on the phenotypic and genotypic characteristics of tumor cells. A new paradigm, scientifically well established and recommended by WHO guidelines, relies on the introduction of the immune response as a new prognostic parameter to predict and refine the clinical outcomes of cancer patients. Maximize patient survival rates with an assessment of the tumor immune response. ...
By Veracyte based in Marseille Cedex 9, FRANCE.
-
RNA Technology for Product Pipeline Research
Our product pipeline shows the progress we’re making on clinical programs currently in development to create mRNA medicines for a wide range of diseases and conditions. We are proud of the advancements we’ve made in pioneering new mRNA vaccines and treatments that may have the potential to treat and prevent rare ...
By Moderna, Inc. based in Cambridge, MASSACHUSETTS (USA).
-
Medical diagnostics solutions for colorectal cancer sector
Colorectal cancer (CRC) is the third most common cancer all over the world. About 1.8 million new CRC cases were diagnosed globally in 2018, mostly in developed countries. The incidence of colorectal cancer is increasing in line with the ageing population. Early detection is key to successful treatment of the disease and related cost management. An efficient screening strategy is essential to detect the disease early, when it often does not produce symptoms. The currently available faecal occult blood test (FOBT) ...
By DiagNodus Ltd. based in Cambridge, UNITED KINGDOM.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you